← Back to headlines
What do we know about the new cholesterol pill, Lipfendra? Merck's new once-a-day drug gets FDA nod
The FDA has approved Merck's once-daily cholesterol pill Lipfendra (enlicitide), marking the first oral PCSK9 inhibitor.
18 Jul, 01:00 — 18 Jul, 01:00
Related Stories
Iran's Ballistic Missile Capability to Strike Ukraine Questioned Amid Escalation
5m ago
Migrant Boat with 39 People Rescued Off Southern Crete
6m ago
Fire Under Investigation at Employment Services Premises in Salo, Finland
12m ago
Spain Investigates Whether Intelligence Warnings on Migrant Influx Were Ignored
14m ago